Abeona Therapeutics (ABEO) News Today $6.56 -0.31 (-4.51%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$6.53 -0.03 (-0.46%) As of 05:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period ABEO FY2025 EPS Forecast Boosted by Cantor FitzgeraldAbeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Equities researchers at Cantor Fitzgerald lifted their FY2025 earnings estimates for Abeona Therapeutics in a report released on Wednesday, April 30th. Cantor Fitzgerald analyst K. Kluska now expects that the biopharmaceutical company will posMay 4 at 8:31 AM | marketbeat.comQ3 EPS Estimate for Abeona Therapeutics Boosted by AnalystAbeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Research analysts at Zacks Small Cap raised their Q3 2025 earnings per share estimates for Abeona Therapeutics in a research report issued on Wednesday, April 30th. Zacks Small Cap analyst D. Bautz now anticipates that the biopharmaceutical coMay 4 at 7:46 AM | marketbeat.comQ2 EPS Forecast for Abeona Therapeutics Decreased by AnalystAbeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Research analysts at HC Wainwright lowered their Q2 2025 earnings per share (EPS) estimates for Abeona Therapeutics in a research report issued to clients and investors on Wednesday, April 30th. HC Wainwright analyst R. Selvaraju now anticipatMay 4 at 7:46 AM | marketbeat.comAbeona Therapeutics Inc (NASDAQ:ABEO) Shares Acquired by 683 Capital Management LLC683 Capital Management LLC boosted its stake in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 17.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 791,845 shares of the biopharmaceutiMay 4 at 7:14 AM | marketbeat.comFY2025 EPS Estimates for ABEO Increased by Cantor FitzgeraldMay 4 at 2:27 AM | americanbankingnews.comQ3 EPS Forecast for Abeona Therapeutics Increased by AnalystMay 4 at 2:27 AM | americanbankingnews.comAbeona Therapeutics Inc (NASDAQ:ABEO) Short Interest UpdateAbeona Therapeutics Inc (NASDAQ:ABEO - Get Free Report) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 2,760,000 shares, a growth of 24.9% from the March 31st total of 2,210,000 shares. Based on an average daily trading volume, of 556,500 shares, the short-interest ratio is presently 5.0 days. Currently, 6.4% of the shares of the company are sold short.May 4 at 2:24 AM | marketbeat.comHC Wainwright Has Negative Estimate for ABEO Q2 EarningsMay 4 at 1:33 AM | americanbankingnews.comQ&A: Two decades of research lead to treatment for rare, painful skin conditionMay 3 at 11:50 PM | msn.comAbeona Therapeutics (NASDAQ:ABEO) Price Target Raised to $20.00May 3 at 1:21 AM | americanbankingnews.comAbeona Therapeutics (NASDAQ:ABEO) Price Target Raised to $20.00 at HC WainwrightHC Wainwright lifted their target price on shares of Abeona Therapeutics from $15.00 to $20.00 and gave the stock a "buy" rating in a research note on Wednesday.May 2 at 8:37 AM | marketbeat.comFDA approves Abeona’s $3.1m cell therapy for rare skin diseaseApril 30, 2025 | msn.comAbeona Therapeutics’ Gene Therapy Gets FDA Nod For Treating Rare Genetic Skin DiseaseApril 29, 2025 | msn.comUS FDA approves Abeona's skin disorder therapyApril 29, 2025 | reuters.comU.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)April 29, 2025 | globenewswire.comAdage Capital Partners GP L.L.C. Has $21.74 Million Stock Position in Abeona Therapeutics Inc (NASDAQ:ABEO)Adage Capital Partners GP L.L.C. raised its position in Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 20.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,902,360 shares ofApril 29, 2025 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Stock Price Passes Above 50-Day Moving Average - Time to Sell?Abeona Therapeutics (NASDAQ:ABEO) Share Price Crosses Above Fifty Day Moving Average - Time to Sell?April 28, 2025 | marketbeat.comAbeona Therapeutics: pz-cel Has Massive Potential For RDEB PatientsApril 21, 2025 | seekingalpha.comWalleye Capital LLC Reduces Stock Holdings in Abeona Therapeutics Inc (NASDAQ:ABEO)Walleye Capital LLC reduced its stake in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 31.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 586,250 shares of the biopharmaceutical company's stock afterApril 20, 2025 | marketbeat.comWellington Management Group LLP Acquires Shares of 93,289 Abeona Therapeutics Inc (NASDAQ:ABEO)Wellington Management Group LLP acquired a new stake in Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 93,289 shares of the biopharmaceutical company's stock, valuedApril 16, 2025 | marketbeat.comTrexquant Investment LP Invests $382,000 in Abeona Therapeutics Inc (NASDAQ:ABEO)Trexquant Investment LP acquired a new position in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 68,516 shares of the biopharmaceutical company's stock, valued at approximately $38April 15, 2025 | marketbeat.comAbeona Therapeutics Inc. Rings the Nasdaq Stock Market Closing BellApril 12, 2025 | nasdaq.comAbeona Therapeutics: A Buy With Major PDUFA Catalyst On April 29 That Should Send Shares HigherApril 12, 2025 | seekingalpha.comAbeona Therapeutics resumed with a Buy at StifelApril 8, 2025 | markets.businessinsider.comAbeona Therapeutics announces employee inducement grantsApril 2, 2025 | markets.businessinsider.comAbeona Therapeutics Inc (NASDAQ:ABEO) CEO Sells $119,500.00 in StockAbeona Therapeutics Inc (NASDAQ:ABEO - Get Free Report) CEO Vishwas Seshadri sold 25,000 shares of Abeona Therapeutics stock in a transaction on Monday, March 31st. The shares were sold at an average price of $4.78, for a total transaction of $119,500.00. Following the completion of the sale, the chief executive officer now directly owns 1,355,322 shares in the company, valued at $6,478,439.16. This represents a 1.81 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.April 1, 2025 | marketbeat.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 1, 2025 | globenewswire.comVishwas Seshadri Sells 25,000 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) StockApril 1, 2025 | insidertrades.comQ3 Earnings Estimate for ABEO Issued By Zacks Small CapAbeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Zacks Small Cap issued their Q3 2025 earnings per share estimates for Abeona Therapeutics in a note issued to investors on Monday, March 24th. Zacks Small Cap analyst D. Bautz anticipates that the biopharmaceutical company will post earnings pMarch 28, 2025 | marketbeat.comHC Wainwright Brokers Lower Earnings Estimates for ABEOAbeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Equities researchers at HC Wainwright dropped their Q1 2025 EPS estimates for shares of Abeona Therapeutics in a note issued to investors on Monday, March 24th. HC Wainwright analyst R. Selvaraju now expects that the biopharmaceutical companyMarch 27, 2025 | marketbeat.comWhat is Zacks Small Cap's Forecast for ABEO Q1 Earnings?Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Investment analysts at Zacks Small Cap issued their Q1 2025 EPS estimates for Abeona Therapeutics in a report issued on Monday, March 24th. Zacks Small Cap analyst D. Bautz anticipates that the biopharmaceutical company will post earnings of (March 27, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for ABEO Q1 Earnings?Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for Abeona Therapeutics in a research note issued on Monday, March 24th. HC Wainwright analyst R. Selvaraju anticipates that the biopharmaceutical company will pMarch 26, 2025 | marketbeat.comStockNews.com Upgrades Abeona Therapeutics (NASDAQ:ABEO) to HoldStockNews.com raised Abeona Therapeutics from a "sell" rating to a "hold" rating in a research report on Monday.March 25, 2025 | marketbeat.comAbeona Therapeutics' (ABEO) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $15.00 price objective on shares of Abeona Therapeutics in a research note on Monday.March 25, 2025 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Upgraded at StockNews.comStockNews.com raised shares of Abeona Therapeutics from a "sell" rating to a "hold" rating in a research note on Monday.March 25, 2025 | marketbeat.comEarnings call transcript: Abeona Therapeutics reports Q4 2024 EPS beatMarch 22, 2025 | uk.investing.comOppenheimer maintains Abeona Therapeutics Outperform ratingMarch 22, 2025 | uk.investing.comAbeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2024 Earnings Call TranscriptMarch 22, 2025 | msn.comAlliance Global Partners Sticks to Its Buy Rating for vTv Therapeutics (VTVT)March 22, 2025 | markets.businessinsider.comAbeona Therapeutics: Positive Outlook Amid FDA HopesMarch 21, 2025 | tipranks.comAbeona Therapeutics (NASDAQ:ABEO) Posts Earnings Results, Beats Estimates By $0.11 EPSAbeona Therapeutics (NASDAQ:ABEO - Get Free Report) announced its quarterly earnings data on Thursday. The biopharmaceutical company reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.35) by $0.11.March 21, 2025 | marketbeat.comAbeona Therapeutics Inc.: Abeona Therapeutics Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch PlansMarch 21, 2025 | finanznachrichten.deAbeona Therapeutics targets $2B revenue potential for pz-cel amid U.S. launch preparationsMarch 21, 2025 | msn.comQ4 2024 Abeona Therapeutics Inc Earnings CallMarch 21, 2025 | finance.yahoo.comAbeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...March 21, 2025 | gurufocus.comAbeona Therapeutics Reports 2024 Financial ResultsMarch 21, 2025 | tipranks.comQ4 2024 Abeona Therapeutics Inc Earnings Call TranscriptMarch 21, 2025 | gurufocus.comAbeona Therapeutics Inc. (ABEO) Q4 2024 Earnings Call TranscriptMarch 20, 2025 | seekingalpha.comAbeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch PlansMarch 20, 2025 | globenewswire.comAbeona Therapeutics at Leerink’s Global Healthcare Conference: Launch Plans for PZcellMarch 12, 2025 | investing.com Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address ABEO Media Mentions By Week ABEO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABEO News Sentiment▼0.500.73▲Average Medical News Sentiment ABEO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABEO Articles This Week▼273▲ABEO Articles Average Week Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OPKO Health News Enliven Therapeutics News Zymeworks News Pharvaris News Geron News Spyre Therapeutics News Mineralys Therapeutics News Harrow News Nurix Therapeutics News Gyre Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABEO) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ABEO Stock Free ABEO Stock Alerts